| RS34713174 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinitis pigmentosa 39 |
| RS34715198 |
POMK
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a |
| RS34716011 |
HBB
|
Health Risk |
Pathogenic |
beta Thalassemia, 8 conditions |
| RS34718174 |
HBB
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS34718443 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS34719006 |
ATP8B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cholestasis, intrahepatic |
| RS34722354 |
DDR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome, Connective tissue disorder |
| RS34723289 |
GNAT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Achromatopsia 4, Achromatopsia 4 |
| RS34725869 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS34731820 |
OCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tyrosinase-positive oculocutaneous albinism, OCA2-related disorder |
| RS34738009 |
ATPAF2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS34738426 |
DSP
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular cardiomyopathy, Arrhythmogenic cardiomyopathy with wooly hair and keratoderma |
| RS34741387 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Tip-toe gait |
| RS34741956 |
MPIG6B
|
Health Risk |
Likely pathogenic |
Thrombocytopenia, anemia |
| RS34747774 |
UTP4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary North American Indian childhood cirrhosis, UTP4-related disorder |
| RS34750035 |
HBB
|
Health Risk |
Pathogenic |
beta Thalassemia, beta Thalassemia |
| RS34751757 |
TNFRSF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
TNF receptor-associated periodic fever syndrome (TRAPS), TNF receptor-associated periodic fever syndrome (TRAPS) |
| RS34754160 |
LAMA3
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS34754243 |
ABCG8
|
Health Risk |
Conflicting classifications of pathogenicity |
Sitosterolemia, Sitosterolemia 1 |
| RS34757931 |
VPS11
|
Health Risk |
Pathogenic/Likely pathogenic |
Leukoencephalopathy, Hypomyelinating leukodystrophy 12 |
| RS34761059 |
NPHS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS34761938 |
TRIP11
|
Health Risk |
Pathogenic |
Achondrogenesis, type IA |
| RS34764419 |
KCNH5
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Early-infantile DEE |
| RS34764749 |
FKBP10
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta type 11, Osteogenesis imperfecta type 11 |
| RS34767364 |
NBN
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly, normal intelligence and immunodeficiency |
| RS34767818 |
DST
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary sensory and autonomic neuropathy type 6, Epidermolysis bullosa simplex 3 |
| RS34768093 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS34769999 |
CLDN9
|
Health Risk |
Likely pathogenic |
Hearing loss, autosomal recessive 116 |
| RS34771391 |
SDHA
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex II deficiency, nuclear type 1 |
| RS34771837 |
ELP4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS34776339 |
BRAF
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, RASopathy |
| RS34778348 |
LRRK2
|
Health Risk |
Conflicting classifications of pathogenicity; risk factor |
Autosomal dominant Parkinson disease 8, Parkinson disease |
| RS34779331 |
TMEM67
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome, Meckel-Gruber syndrome |
| RS34779890 |
SDHA
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex II deficiency, nuclear type 1 |
| RS34788119 |
EXPH5
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS34788341 |
GNPTAB
|
Health Risk |
Pathogenic |
Pseudo-Hurler polydystrophy, Mucopolysaccharidosis |
| RS34791072 |
TBCD
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome, Inborn genetic diseases |
| RS34792388 |
ACTB
|
Health Risk |
Conflicting classifications of pathogenicity |
Baraitser-Winter syndrome 1, Baraitser-Winter syndrome 1 |
| RS34794176 |
SCEL
|
Health Risk |
Likely pathogenic |
Moyamoya angiopathy, Moyamoya angiopathy |
| RS34796823 |
PKHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive polycystic kidney disease, Autosomal recessive polycystic kidney disease |
| RS34799090 |
GATA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Deafness-lymphedema-leukemia syndrome, Monocytopenia with susceptibility to infections |
| RS34803727 |
SLC12A3
|
Health Risk |
Likely pathogenic |
Familial hypokalemia-hypomagnesemia, Bartter syndrome |
| RS34804482 |
LGR4
|
Health Risk |
Pathogenic |
Delayed puberty, self-limited |
| RS34805604 |
LRRK2
|
Health Risk |
Pathogenic |
Autosomal dominant Parkinson disease 8, Autosomal dominant Parkinson disease 8 |
| RS34809449 |
HBG2
|
Health Risk |
Pathogenic |
Hereditary persistence of fetal hemoglobin, Hereditary persistence of fetal hemoglobin |
| RS34809608 |
P3H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta type 8, Osteogenesis Imperfecta |
| RS34809925 |
HBB
|
Health Risk |
Pathogenic/Likely pathogenic |
beta Thalassemia, Beta thalassemia intermedia |
| RS34812788 |
AMT
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycine encephalopathy, Glycine encephalopathy |
| RS34813378 |
C1QB
|
Health Risk |
Likely pathogenic |
C1Q deficiency, C1Q deficiency |
| RS34813787 |
CDH3
|
Health Risk |
Conflicting classifications of pathogenicity |
EEM syndrome, EEM syndrome |
| RS34816083 |
UNC79
|
Health Risk |
Conflicting classifications of pathogenicity |
Prostate cancer, Prostate cancer |
| RS34819316 |
SLC12A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bartter disease type 1, SLC12A1-related disorder |
| RS34830422 |
COL12A1
|
Health Risk |
Pathogenic |
Ullrich congenital muscular dystrophy 2, Bethlem myopathy 2 |
| RS34830702 |
STXBP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, STXBP1-related disorder |
| RS34830861 |
PIEZO1
|
Health Risk |
Conflicting classifications of pathogenicity |
PIEZO1-related disorder, PIEZO1-related disorder |
| RS34831026 |
HBB
|
Health Risk |
Conflicting classifications of pathogenicity |
HEMOGLOBIN ATHENS-GEORGIA, 8 conditions |
| RS34831847 |
HBB
|
Health Risk |
Pathogenic |
beta Thalassemia, beta Thalassemia |
| RS34832733 |
APOA5
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS34833100 |
SPDL1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS34840340 |
TBCK
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, TBCK-related disorder |
| RS34846075 |
MYO10
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS34849215 |
IFNAR1
|
Health Risk |
Pathogenic/Likely pathogenic |
Immunodeficiency 106, susceptibility to viral infections |
| RS34851638 |
TECTA
|
Health Risk |
Pathogenic/Likely pathogenic |
Hearing impairment, Hearing impairment |
| RS34856125 |
GAD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities, Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities |
| RS34856846 |
HBB
|
Health Risk |
Pathogenic |
Beta zero thalassemia, Hemoglobinopathy |
| RS34859138 |
CEP250
|
Health Risk |
Pathogenic |
— |
| RS34864794 |
ZNF142
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodevelopmental disorder with impaired speech and hyperkinetic movements, Neurodevelopmental disorder with impaired speech and hyperkinetic movements |
| RS34870876 |
GATA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Deafness-lymphedema-leukemia syndrome, Monocytopenia with susceptibility to infections |
| RS34873950 |
PIEZO1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS34875116 |
MAGEL2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS34876841 |
CTSC
|
Health Risk |
Pathogenic/Likely pathogenic |
Haim-Munk syndrome, Papillon-Lefèvre syndrome |
| RS34878178 |
G6PC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency, G6PC3-related disorder |
| RS34878385 |
KANSL1
|
Health Risk |
Likely pathogenic |
— |
| RS34878847 |
TYR
|
Health Risk |
Conflicting classifications of pathogenicity |
Oculocutaneous albinism, Oculocutaneous albinism type 1A |
| RS34883113 |
HBA1
|
Health Risk |
Pathogenic |
alpha Thalassemia, Hemoglobin H disease |
| RS34883338 |
HBB
|
Health Risk |
Pathogenic/Likely pathogenic |
BETA-PLUS-THALASSEMIA, beta Thalassemia |
| RS34884895 |
DSP
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Arrhythmogenic right ventricular dysplasia 8 |
| RS34885143 |
BTD
|
Health Risk |
Conflicting classifications of pathogenicity |
Biotinidase deficiency, BTD-related disorder |
| RS34885858 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS34886500 |
CDKN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Melanoma-pancreatic cancer syndrome, Familial melanoma |
| RS34886778 |
SPTA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spherocytosis type 3, Elliptocytosis 2 |
| RS34889882 |
HBB
|
Health Risk |
Pathogenic |
Beta zero thalassemia, beta Thalassemia |
| RS34890640 |
JUP
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Arrhythmogenic right ventricular dysplasia 12 |
| RS34890806 |
GUCY2C
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Intestinal obstruction in the newborn due to guanylate cyclase 2C deficiency |
| RS34893635 |
PLEC
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa simplex, Ogna type |
| RS34901902 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-A |
| RS34908868 |
STAR
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital lipoid adrenal hyperplasia due to STAR deficency, STAR-related disorder |
| RS34911341 |
GHRL
|
Health Risk |
risk factor |
Metabolic syndrome, susceptibility to |
| RS34911705 |
MPDZ
|
Health Risk |
Conflicting classifications of pathogenicity |
Hydrocephalus, nonsyndromic |
| RS34911792 |
CFTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Cystic fibrosis, CFTR-related disorder |
| RS34915313 |
TRPM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital stationary night blindness 1C, Congenital stationary night blindness 1C |
| RS34916226 |
CUL7
|
Health Risk |
Conflicting classifications of pathogenicity |
CUL7-related disorder, 3M syndrome 1 |
| RS34919986 |
FBN1
|
Health Risk |
Pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS34921128 |
NSD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Sotos syndrome |
| RS34924076 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Mucolipidosis type II |
| RS34924609 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiomyopathy |
| RS34925776 |
TTC21B
|
Health Risk |
Conflicting classifications of pathogenicity |
Jeune thoracic dystrophy, Nephronophthisis |
| RS34927195 |
NLGN3
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS34928783 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Charlevoix-Saguenay spastic ataxia |
| RS34928857 |
PNPT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined oxidative phosphorylation defect type 13, Autosomal recessive nonsyndromic hearing loss 70 |